Silexion Therapeutics (SLXN) Misses Q3 EPS by 288c
Tweet
Share
E-mailGet Alerts SLXN Hot Sheet
Join SI Premium – FREE
Silexion Therapeutics (NASDAQ: SLXN) reported Q3 EPS of ($2.88).
For earnings history and earnings-related data on Silexion Therapeutics (SLXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sodexo (SW:FP) (SDXAY) PT Raised to EUR58.60 at Bernstein SocGen Group
- Docusign shares soar on strong Q2 print, upbeat ARR guidance
- BTIG Reiterates Neutral Rating on Oxford Industries (OXM)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
